Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy
Preeti Gupta, Taj Mohammad, Rashmi Dahiya, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review
Shabnam Ghahremanian, Mohammad Mehdi Rashidi, Kimai Raeisi, et al.
Journal of Molecular Liquids (2022) Vol. 354, pp. 118901-118901
Open Access | Times Cited: 123
Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies
Taj Mohammad, Shiza Siddiqui, Anas Shamsi, et al.
Molecules (2020) Vol. 25, Iss. 4, pp. 823-823
Open Access | Times Cited: 124
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
Anas Shamsi, Saleha Anwar, Taj Mohammad, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 789-789
Open Access | Times Cited: 95
Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6
Mohd Yousuf, Anas Shamsi, Parvez Κhan, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3526-3526
Open Access | Times Cited: 93
Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy
Saleha Anwar, Taj Mohammad, Anas Shamsi, et al.
Biomedicines (2020) Vol. 8, Iss. 5, pp. 119-119
Open Access | Times Cited: 86
Identification of natural compounds as potent inhibitors of SARS-CoV-2 main protease using combined docking and molecular dynamics simulations
Deeba Shamim Jairajpuri, Afzal Hussain, Khalida Nasreen, et al.
Saudi Journal of Biological Sciences (2021) Vol. 28, Iss. 4, pp. 2423-2431
Open Access | Times Cited: 69
Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches
Agneesh Pratim Das, Subhash Mohan Agarwal
Molecular Diversity (2023) Vol. 28, Iss. 2, pp. 901-925
Open Access | Times Cited: 25
Biochemical features and therapeutic potential of α-Mangostin: Mechanism of action, medicinal values, and health benefits
Manzar Alam, Summya Rashid, Kisa Fatima, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114710-114710
Open Access | Times Cited: 23
Exploring MTH1 inhibitory potential of Thymoquinone and Baicalin for therapeutic targeting of breast cancer
Aaliya Taiyab, Arunabh Choudhury, Shaista Haidar, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116332-116332
Open Access | Times Cited: 10
Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy
Mohd Yousuf, Parvez Κhan, Anas Shamsi, et al.
ACS Omega (2020) Vol. 5, Iss. 42, pp. 27480-27491
Open Access | Times Cited: 66
Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma
Christian Bailly
Chemico-Biological Interactions (2020) Vol. 325, pp. 109124-109124
Closed Access | Times Cited: 61
Structure-based identification of potential SARS-CoV-2 main protease inhibitors
Shama Khan, Zeynab Fakhar, Afzal Hussain, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 8, pp. 3595-3608
Open Access | Times Cited: 57
Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy
Preeti Gupta, Aaliya Taiyab, Afzal Hussain, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1898-1898
Open Access | Times Cited: 51
Identification of Sphingosine Kinase-1 Inhibitors from Bioactive Natural Products Targeting Cancer Therapy
Deeba Shamim Jairajpuri, Taj Mohammad, Kirtika Adhikari, et al.
ACS Omega (2020) Vol. 5, Iss. 24, pp. 14720-14729
Open Access | Times Cited: 49
Pharmacological features, health benefits and clinical implications of honokiol
Fatima Khatoon, Sabeeha Ali, Vijay Kumar, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 15, pp. 7511-7533
Closed Access | Times Cited: 28
PF543-like compound, a promising sphingosine kinase 1 inhibitor: Structure-based virtual screening and molecular dynamic simulation approaches
Moyad Shahwan, Nageeb Hassan, Akram Ashames, et al.
International Journal of Biological Macromolecules (2023) Vol. 245, pp. 125466-125466
Closed Access | Times Cited: 16
Targeting prostate cancer via therapeutic targeting of PIM-1 kinase by Naringenin and Quercetin
Aanchal Rathi, Arunabh Chaudhury, Farah Anjum, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 133882-133882
Closed Access | Times Cited: 5
Identification and evaluation of glutathione conjugate gamma-l-glutamyl-l-cysteine for improved drug delivery to the brain
Saman Fatima, Taj Mohammad, Deeba Shamim Jairajpuri, et al.
Journal of Biomolecular Structure and Dynamics (2019) Vol. 38, Iss. 12, pp. 3610-3620
Closed Access | Times Cited: 52
Identification of High-Affinity Inhibitors of Cyclin-Dependent Kinase 2 Towards Anticancer Therapy
Taj Mohammad, Sagar Batra, Rashmi Dahiya, et al.
Molecules (2019) Vol. 24, Iss. 24, pp. 4589-4589
Open Access | Times Cited: 49
Identification of Potential Inhibitors of Calcium/Calmodulin-Dependent Protein Kinase IV from Bioactive Phytoconstituents
Preeti Gupta, Shama Khan, Zeynab Fakhar, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 47
Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer
Sonam Roy, Taj Mohammad, Preeti Gupta, et al.
ACS Omega (2020) Vol. 5, Iss. 34, pp. 21550-21560
Open Access | Times Cited: 47
Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer’s disease
Ahmad Abu Turab Naqvi, Deeba Shamim Jairajpuri, Omar M. Noman, et al.
Journal of Biomolecular Structure and Dynamics (2019) Vol. 38, Iss. 13, pp. 3892-3907
Closed Access | Times Cited: 44
Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases
Saleha Anwar, Anas Shamsi, Rajiv K. Kar, et al.
International Journal of Biological Macromolecules (2020) Vol. 161, pp. 596-604
Closed Access | Times Cited: 40
Identification of plant-based hexokinase 2 inhibitors: combined molecular docking and dynamics simulation studies
Asifa Khan, Taj Mohammad, Anas Shamsi, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 20, pp. 10319-10331
Closed Access | Times Cited: 36
Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase
Farah Anjum, Taj Mohammad, Abdulraheem Ali Almalki, et al.
OMICS A Journal of Integrative Biology (2021) Vol. 25, Iss. 9, pp. 580-590
Closed Access | Times Cited: 35
Page 1 - Next Page

Scroll to top